BCL2L1 antibody (pSer62)
Quick Overview for BCL2L1 antibody (pSer62) (ABIN2888371)
Target
See all BCL2L1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer62
-
Specificity
- BCL-XL (Phospho-Ser62) Antibody detects endogenous levels of BCL-XL only when phosphorylated at serine62.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human BCL-XL around the phosphorylation site of Ser62.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (1:50 - 1:100), Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for up to 1 year.
-
Expiry Date
- 12 months
-
-
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Alternative Name
- BCL2L1 / BCL-XL
-
Background
-
Name/Gene ID: BCL2L1
Family: Apoptosis
Synonyms: BCL2L1, Apoptosis regulator Bcl-X, Bcl-xL, BCL-XL/S, BCLXS, Bcl-2-like protein 1, BCL2-like 1, BCL2L, Bcl-X, Bcl-xS, BCLXL, PPP1R52, Bcl2-L-1, BCLX -
Gene ID
- 598
-
UniProt
- Q07817
-
Pathways
- Apoptosis, Negative Regulation of intrinsic apoptotic Signaling
Target
-